News Website

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - Morningstar

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) Morningstar

Published: Nov. 13, 2025, 3:15 p.m.

Read Full Article

'Strong and Healthy' Amy Schumer Reveals Why She Deleted Her Pre-Weight Loss Photos on Instagram: 'I'm Proud of How I've Looked Always' - okmagazine.com

'Strong and Healthy' Amy Schumer Reveals Why She Deleted Her Pre-Weight Loss Photos on Instagram: 'I'm Proud of How I've Looked Always' okmagazine.com

Published: Nov. 13, 2025, 12:15 p.m.

Read Full Article

Sinn Féin expels party member after arrest of her partner in far-right terror probe - The Journal

Sinn Féin expels party member after arrest of her partner in far-right terror probe The Journal

Published: Nov. 13, 2025, 11:32 a.m.

Read Full Article

Amy Schumer clarifies why she deleted all of her pre-weight loss photos - Film-News.co.uk

Amy Schumer clarifies why she deleted all of her pre-weight loss photos Film-News.co.uk

Published: Nov. 13, 2025, 11:17 a.m.

Read Full Article

Amy Schumer rejects claims she deleted all her Instagram pics because they were pre-weight loss - LADbible

Amy Schumer rejects claims she deleted all her Instagram pics because they were pre-weight loss LADbible

Published: Nov. 13, 2025, 10 a.m.

Read Full Article

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech

Published: Nov. 13, 2025, 9 a.m.

Read Full Article

Amy Schumer reveals why she deleted pre-weight-loss posts on Instagram - NewsBytes

Amy Schumer reveals why she deleted pre-weight-loss posts on Instagram NewsBytes

Published: Nov. 13, 2025, 8:29 a.m.

Read Full Article

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care - PR Newswire UK

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care PR Newswire UK

Published: Nov. 13, 2025, 8 a.m.

Read Full Article

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.

Read Full Article

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.

Read Full Article

Latest Articles

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - Morningstar

'Strong and Healthy' Amy Schumer Reveals Why She Deleted Her Pre-Weight Loss Photos on Instagram: 'I'm Proud of How I've Looked Always' - okmagazine.com

Sinn Féin expels party member after arrest of her partner in far-right terror probe - The Journal

Amy Schumer clarifies why she deleted all of her pre-weight loss photos - Film-News.co.uk

Amy Schumer rejects claims she deleted all her Instagram pics because they were pre-weight loss - LADbible

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech

Amy Schumer reveals why she deleted pre-weight-loss posts on Instagram - NewsBytes

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care - PR Newswire UK

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

Subscribe to Our Newsletter